Stockreport

MindMed Reports 2023 Financial Results and Business Updates

Mind Medicine (MindMed) Inc. - Common Shares  (MNMD) 
PDF --Announced statistically significant and clinically meaningful topline Phase 2b data for MM120 at 4 weeks in Generalized Anxiety Disorder (GAD)----Multiple planned mile [Read more]